Wee1 kinase inhibitors(Schrodinger)

N/A

Report date: 2021/12/23 16:51:08
NME

Base Information

Drug NameWee1 kinase inhibitors(Schrodinger)
Drug Alias NameSDGR-2SDGR2-WEE1SDGR-2-WEE-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase WEE1 inhibitors
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSchrodinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A